Evocalcet: A New Oral Calcimimetic for Dialysis Patients With Secondary Hyperparathyroidism-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evocalcet: A New Oral Calcimimetic for Dialysis Patients With Secondary Hyperparathyroidism

Published:2019-10-23 Issue:3 Volume:24 Page:248-257
ISSN:1744-9979
Container-title:Therapeutic Apheresis and Dialysis
language:en
Short-container-title:Ther Apher Dial

Author:

Akizawa Tadao¹,Ikejiri Kazuaki²^ORCID,Kondo Yuichiro²,Endo Yuichi²,Fukagawa Masafumi³

Affiliation:

1. Division of Nephrology, Department of Medicine Showa University School of Medicine Tokyo Japan

2. R&D Division, Kyowa Kirin Co., Ltd. Tokyo Japan

3. Division of Nephrology Endocrinology and Metabolism, Tokai University School of Medicine Kanagawa Japan

Publisher

Wiley

Subject

Nephrology,Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1744-9987.13434

Reference49 articles.

1. Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

2. Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis

3. Secondary Hyperparathyroidism: Pathogenesis and Latest Treatment

4. Diseases of the parathyroid gland in chronic kidney disease

5. Secondary Hyperparathyroidism: Pathogenesis, Disease Progression, and Therapeutic Options

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current therapeutic approach of chronic kidney disease‐mineral and bone disorder;Therapeutic Apheresis and Dialysis;2024-06-19

2. Pre-Transplant Calcimimetic Use and Dose Information Improves the Accuracy of Prediction of Tertiary Hyperparathyroidism after Kidney Transplantation: A Retrospective Cohort Study;Transplant International;2024-05-01

3. Silicon-Rhodamine Functionalized Evocalcet Probes Potently and Selectively Label Calcium Sensing Receptors In Vitro, In Vivo, and Ex Vivo;ACS Pharmacology & Translational Science;2024-04-25

4. G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery;Signal Transduction and Targeted Therapy;2024-04-10

5. Long-term treatment of evocalcet in hemodialysis patients with secondary hyperparathyroidism: a five-year prospective cohort study in 147 Japanese patients;Renal Replacement Therapy;2024-03-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3